Last updated: 18 July 2019 at 8:22pm EST

Carl W Balezentis Net Worth




The estimated Net Worth of Carl W Balezentis is at least $94.1 mil dollars as of 15 December 2010. Carl Balezentis owns over 12,724 units of Enzo Biochem stock worth over $28,805 and over the last 17 years Carl sold ENZ stock worth over $65,334.

Carl Balezentis ENZ stock SEC Form 4 insiders trading

Carl has made over 2 trades of the Enzo Biochem stock since 2010, according to the Form 4 filled with the SEC. Most recently Carl sold 12,724 units of ENZ stock worth $65,147 on 15 December 2010.

The largest trade Carl's ever made was selling 12,724 units of Enzo Biochem stock on 15 December 2010 worth over $65,147. On average, Carl trades about 2,126 units every 42 days since 2007. As of 15 December 2010 Carl still owns at least 25,950 units of Enzo Biochem stock.

You can see the complete history of Carl Balezentis stock trades at the bottom of the page.



What's Carl Balezentis's mailing address?

Carl's mailing address filed with the SEC is C/O ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK, NY, 10022.

Insiders trading at Enzo Biochem

Over the last 22 years, insiders at Enzo Biochem have traded over $2,615,763 worth of Enzo Biochem stock and bought 1,070,494 units worth $3,103,461 . The most active insiders traders include Bradley Louis Radoff, Management Corp Harbert Dis... y Elazar Rabbani. On average, Enzo Biochem executives and independent directors trade stock every 127 days with the average trade being worth of $59,099. The most recent stock trade was executed by Kara Cannon on 21 February 2024, trading 10,640 units of ENZ stock currently worth $11,810.



What does Enzo Biochem do?

enzo biochem inc is a financial services company located in 60 executive blvd, farmingdale, new york, united states.



What does Enzo Biochem's logo look like?

Enzo Biochem, Inc. logo

Complete history of Carl Balezentis stock trades at Enzo Biochem

Fecha
#
Empresa
Persona
Trans.
Transacción
Acciones Precio por acción Precio total Acciones después de Fuente
15 Dec 2010 Carl W Balezentis
Pres. y Enzo Life Sciences
Venta 12,724 $5.12 $65,147
15 Dec 2010
25,950
7 Apr 2010 Carl W Balezentis
Pres. y Enzo Life Sciences
Venta 30 $6.23 $187
7 Apr 2010
35,724


Enzo Biochem executives and stock owners

Enzo Biochem executives and other stock owners filed with the SEC include: